Brian G. Atwood 13D and 13G filings for CERo Therapeutics Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-07 5:21 pm Purchase | 2025-02-07 | 13D | CERo Therapeutics Holdings, Inc. CERO | Brian G. Atwood | 202,404 6.700% | 5,081 (+2.57%) | Filing |
| 2024-10-30 8:58 pm Purchase | 2024-09-25 | 13D | CERo Therapeutics Holdings, Inc. CERO | Brian G. Atwood | 197,323 13.400% | 197,323 (New Position) | Filing |